Japanese scientists will use artificial intelligence to "plug in" drug development
According to the news, Kyoto University of Japan has joined forces with a number of companies to set up relevant institutions for the development of artificial intelligence for the development of new drugs. It is reported that the establishment of the agency is to significantly reduce the cost of research and development of drugs. According to relevant statistics, the development cycle of all drugs entering the clinical trial phase is about 10 years, and the research and development expenditure is as high as 2.6 billion US dollars. In addition, less than 12% of the drugs can finally be marketed. “The drug cycle developed through artificial intelligence can be shortened to three years and costs reduced by half,†said the project leader. He also said that the work of artificial intelligence in drug development includes locking in pathogenic proteins, screening for pharmaceutical ingredients that act on proteins, assessing the safety of pharmaceutical ingredients, determining synthesis methods, and developing clinical trial plans to determine efficacy. It is reported that only one drug component is screened. In the past, it was time-consuming and labor-intensive to investigate a large number of domestic and foreign medical papers and data by pharmaceutical companies, and artificial intelligence can process huge medical literature data more quickly. This move is not a temporary "brain-heat" behavior in Japan. It is understood that artificial intelligence has appeared in Japan's medical service system as early as a few months ago. In order to solve the language problem of foreigners seeking medical treatment in Japan, 20 hospitals including the University of Tokyo Hospital cooperated with related companies, and on April 1st, they launched a medical field translation device, which can connect doctors and patients in Japanese and English and Chinese are translated in the form of words and sounds. The promotion of the translation system will undoubtedly help foreigners to eliminate communication problems in Japan. After a successful trial in the medical service field, a few months later, artificial intelligence was seamlessly connected to Japan for the development of new drugs. It is worth mentioning that the project has also received strong support from the Japanese government. It is reported that in order to enable artificial intelligence to help Japan improve its international competitiveness, the Japanese government will also provide 500 million yen of research funds for the project. In addition, the project has also received support from a large number of Japanese companies such as Fujitsu and Takeda Pharmaceutical Industries. According to the survey, as another emerging field in the artificial intelligence world, in addition to Japan, many companies in the industry have been involved before. For example, Atomwise in the United States has designed a system called AtomNet that uses supercomputers, AI and sophisticated algorithms to simulate pharmaceutical processes to predict the effects of new drugs, speed up the development of new drugs and minimize costs. Various dehydrated carrot products made through multiple processes have different specifications according to different requirements, including dehydrated carrot wafers, dehydrated carrot granules, etc. Each product is made of high-quality raw materials to retain the nutritional value of the original plants. Dehydrated Carrot Products,Dehydrated Carrot Granules,Dehydrated Carrot Slices,Dehydrated Carrot Powder Xinghua Lvwei Foods Co.,Ltd , https://www.lvweifoods.com